123 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
22 May 24
2024 Annual General Meeting of Shareholders
4:15pm
or other office holder of ours, if you hold 50% or more of the voting rights in our Company or have the right to appoint the majority of the directors
POS AM
CANF
Can-Fite Biopharma Ltd
5 Apr 24
Prospectus update (post-effective amendment)
4:15pm
% of the total outstanding voting rights.
A meeting adjourned for lack of a quorum is adjourned to the same day in the following week at the same time … at a shareholders meeting requires approval by a simple majority of the voting rights represented at the meeting, in person, by proxy or written ballot
F-3/A
xb8o01
28 Dec 23
Shelf registration (foreign) (amended)
4:16pm
F-3
5q1ylul
12 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-10.2
6523z7gru0dj
22 Nov 23
Report of Foreign Private Issuer
4:15pm
6-K
dw82h9
22 Nov 23
Report of Foreign Private Issuer
4:15pm
6-K
EX-10.3
fcmcsszwa9u ft1ei
22 Nov 23
Report of Foreign Private Issuer
4:15pm
POS AM
k211u3hvczor q4
1 Sep 23
Prospectus update (post-effective amendment)
4:16pm
F-3
8o3iw2j1zmn9z37
1 Sep 23
Shelf registration (foreign)
4:15pm
6-K
EX-99.1
62y6x53dpn0gnli6sj4
23 Jun 23
2023 Annual General Meeting of Shareholders
4:15pm
POS AM
rn0wh97i4j811qxx
21 Apr 23
Prospectus update (post-effective amendment)
4:16pm
POS AM
xfbd32c
31 Mar 23
Prospectus update (post-effective amendment)
4:30pm
POS AM
mub5mutc76pc2pv
26 Aug 22
Prospectus update (post-effective amendment)
4:31pm
6-K
EX-99.1
s0a41a5z
25 Jul 22
Report of Foreign Private Issuer
4:30pm
POS AM
r63jfrexi68c3d9fnf8r
25 Mar 22
Prospectus update (post-effective amendment)
4:30pm